|
Chlorocebus aethiops
|
BAO_0002639 |
|
|
C5a receptor antagonist
|
CHEBI_144895 |
|
|
G-protein-coupled receptor antagonist
|
CHEBI_88295 |
|
|
native conformation
|
BAO_0002630 |
|
|
protein modification method
|
BAO_0002632 |
|
|
elongated neurite phenotype
|
BAO_0170026 |
|
|
neuronal morphology phenotype
|
BAO_0170022 |
|
|
fasciculated axons phenotype
|
BAO_0170027 |
|
|
branched neurite phenotype
|
BAO_0170024 |
|
|
defasciculated axon bundles phenotype
|
BAO_0170025 |
|
|
EC 6.1.1.12 (aspartate--tRNA ligase) inhibitor
|
CHEBI_82756 |
|
|
NF-KappaB p65 translocation phenotype
|
BAO_0170020 |
|
|
molecular localization phenotype
|
BAO_0170019 |
|
|
molecular expression phenotype
|
BAO_0170021 |
|
|
protein L-based affinity purification method
|
BAO_0002608 |
|
|
affinity purification method
|
BAO_0002603 |
|
|
antibody isotype
|
BAO_0002609 |
|
|
Aurora kinase inhibitor
|
CHEBI_70770 |
|
|
antibody preparation method
|
BAO_0002601 |
|
|
ammonium sulfate precipitation method
|
BAO_0002602 |
|
